GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jeil Pharma Holdings Inc (XKRX:002620) » Definitions » Other Long Term Assets

Jeil Pharma Holdings (XKRX:002620) Other Long Term Assets : ₩207,381 Mil (As of Mar. 2024)


View and export this data going back to 1988. Start your Free Trial

What is Jeil Pharma Holdings Other Long Term Assets?

Jeil Pharma Holdings's other long-term assets for the quarter that ended in Mar. 2024 was ₩207,381 Mil.

Jeil Pharma Holdings's quarterly other long-term assets increased from Sep. 2023 (₩198,301 Mil) to Dec. 2023 (₩208,652 Mil) but then stayed the same from Dec. 2023 (₩208,652 Mil) to Mar. 2024 (₩207,381 Mil).

Jeil Pharma Holdings's annual other long-term assets increased from Dec. 2021 (₩188,730 Mil) to Dec. 2022 (₩196,702 Mil) and increased from Dec. 2022 (₩196,702 Mil) to Dec. 2023 (₩208,652 Mil).

Jeil Pharma Holdings Other Long Term Assets Historical Data

The historical data trend for Jeil Pharma Holdings's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeil Pharma Holdings Other Long Term Assets Chart

Jeil Pharma Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 195,190.60 208,909.09 188,730.11 196,702.28 208,651.93

Jeil Pharma Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 193,276.05 196,090.32 198,301.30 208,651.93 207,381.36

Jeil Pharma Holdings Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Jeil Pharma Holdings (XKRX:002620) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jeil Pharma Holdings Inc (XKRX:002620) » Definitions » Other Long Term Assets
Comparable Companies
XKRX:176750 XKRX:214390 XKRX:023910 XKRX:082800 XKRX:061250 XKRX:002390 XKRX:006620 XKRX:003120 XKRX:002210 XKRX:389470 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
745-5, Banpo-dong, Seocho-gu, Seoul, KOR, 137-810
Website
https://www.jeilpharm.co.kr
Jeil Pharma Holdings Inc is involved in manufacture and distribution of pharmaceutical products. The company mainly produces finished pharmaceutical products and active pharmaceutical ingredients. It has categorized its products in Antibiotic, Oncology, Cardiovascular, Gastrointestinal, Urology, Respiratory etc. The firm's manufacturing facility and research and development institute located at Yongin-si, Gyeonggi-do in Korea.

Jeil Pharma Holdings (XKRX:002620) Headlines

No Headlines